Life Sciences Companies in San Diego

Overview

San Diego is the third-largest biotech cluster in the United States, trailing only Boston/Cambridge and the San Francisco Bay Area. The cluster is anchored by UC San Diego, Scripps Research, the Salk Institute, and a decades-long concentration of biopharmaceutical, genomics, and medical device companies in the Torrey Pines and Sorrento Valley corridors. This audience covers 1,700+ life sciences companies in San Diego, enriched with sub-sector classification, funding stage, clinical pipeline stage where available, and academic or research institution affiliations that indicate spin-out origin or ongoing research partnerships.

What's Included

• Company Identity: Company name, website, and San Diego location (Torrey Pines, Sorrento Valley, downtown, La Jolla)
• Sub-Sector: Life sciences classification (biopharmaceutical, genomics, medical device, diagnostics, digital health, CRO/CDMO, life sciences tools and reagents)
• Funding and Stage: Funding stage, total raised, and clinical pipeline stage (preclinical, Phase I/II/III, commercial)
• Affiliations: Academic and research institution affiliations (UCSD, Scripps, Salk, JLABS)
• Contacts: CEO, CFO, CSO, VP R&D, VP Operations, and scientific leadership with verified email and phone

Use Cases

San Diego Life Sciences Platform and CRO Sales

Contract research organizations, clinical trial management systems, regulatory submissions platforms, and life sciences data tools target San Diego biotech companies across the clinical development spectrum. Pipeline stage enrichment drives stage-appropriate outreach — a preclinical company needs different services than a Phase III program approaching NDA submission.

Lab Equipment and Reagent Sales

Scientific instrument vendors, lab automation providers, CRISPR and genomics reagent suppliers, and consumables distributors target San Diego's dense cluster of research-stage biotech companies. Funding recency and employee count signal purchasing capacity and procurement formality — early-stage labs buy differently than established mid-size biopharma.

Biotech Investor Deal Sourcing

Life sciences investors — venture capital, crossover funds, and family offices with biotech mandates — active in San Diego can use pipeline stage and funding data to identify companies approaching value inflection points, program milestones, or next-round fundraising.

Scientific Recruiting and Talent Acquisition

Life sciences executive search firms, academic recruiting platforms, and talent networks can use funding recency, pipeline stage, and employee growth as signals of active hiring — particularly at companies post-Series A or post-IND filing, where team-building accelerates ahead of clinical execution.